In vitro silencing of CLDN6 in HEC-1-B endometrial cancer cells significantly reduced proliferation, migration, and invasion, accompanied by downregulation of the PI3K/AKT/mTOR pathway. This evidence concerns the gene CLDN6 and endometrial cancer.